Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury

Nephrology Dialysis Transplantation

Volumn 31, Issue 10, 2016, Pages 1633-1640

  Heung, Michael ^a   Ortega, Luis M ^b   Chawla, Lakhmir S ^c   Wunderink, Richard G ^d   Self, Wesley H ^e   Koyner, Jay L ^f   Shi, Jing ^g   Kellum, John A ^h  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g Walker Bioscience   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

acute kidney injury; biomarkers; chronic kidney disease

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN;

ACUTE KIDNEY FAILURE; ADULT; AGE DISTRIBUTION; AGED; BODY MASS; CELL CYCLE ARREST; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ACUTE KIDNEY INJURY; CELL CYCLE CHECKPOINT; CHRONIC DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

ACUTE KIDNEY INJURY; AGED; BIOMARKERS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CHRONIC DISEASE; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; ROC CURVE;

EID: 84994908344     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw241     Document Type: Conference Paper

References (24)

1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818
2. Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-Analysis. Clin J Am Soc Nephrol 2013; 8: 1482-1493
3. Lafrance JP, Miller DR. Acute kidney injury associates with increased longterm mortality. J Am Soc Nephrol 2010; 21: 345-352
4. Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-Term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005; 9: R700-R709
5. Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012; 2: 1-138
6. Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79: 1119-1130
7. Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371: 58-66
8. Kashani K, Al-Khafaji A, Ardiles Tet al. Discoveryand validationof cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25
9. Bihorac A, Chawla LS, Shaw AD, et al.Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication Am J Respir Crit Care Med 2014 189 932-939
10. Yang QH, Liu DW, Long Y, et al. Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 2009; 58: 459-464
11. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520
12. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77
13. Hoste EA, McCullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkersz. Nephrol Dial Transplant 2014; 29: 2054-2061
14. Lameire NH, Vanholder RC, Van Biesen WA. How to use biomarkers efficiently in acute kidney injury. Kidney Int 2011; 79: 1047-1050
15. Koyner JL, Vaidya VS, Bennett MRet al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010; 5: 2154-2165
16. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinaseassociated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337-344
17. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, et al. Neutrophil gelatinase-Associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc 2009; 41: 158-161
18. van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212: 209-217
19. Gardiner L, Akintola A, Chen G, et al. Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease. Am J Nephrol 2012; 35: 152-163
20. Lin Q, Chen Y, Lv J, et al. Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation. Am J Physiol Renal Physiol 2014; 306: F885-F895
21. McCullough PA, Shaw AD, Haase M, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013; 182: 13-29
22. Haase M, Kellum JA, Ronco C. Subclinical AKI-An emerging syndrome with important consequences. Nat Rev Nephrol 2012; 8: 735-739
23. Ahmed SA, Hamed MA. Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patients. J Diabetes Metab Disord 2015; 14: 6
24. Sabbisetti VS, Waikar SS, Antoine DJ, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol 2014; 25: 2177-2186